Key result
Surgical resection with synthetic graft replacement successfully manages rare monophasic synovial spindle cell sarcoma.
Why the study?
Synovial sarcoma is a rare soft tissue sarcoma with unclear etiology and high rates of misdiagnosis and metastasis at diagnosis.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Synovial sarcoma is a rare neoplasm that requires high clinical suspicion and proper preoperative diagnostic guidelines to reduce morbidity and mortality.
INTRODUCTION AND IMPORTANCE: Synovial sarcoma (SS) is a rare form of Soft Tissue Sarcoma (STS) which results from the malignant proliferation of mesenchymal cells. Specific etiologies are not yet known, and its incidence rate ranges between 0.81 and 1.42 per 1 million individuals. Its gender-specific prevalence is almost the same between males and females and it is unique from other subtypes of STS in that it's slow growing and in almost half the cases, patients present with distant metastasis at the time of diagnosis. CASE PRESENTATION: We present the case of a 46-year-old previously healthy male patient, who complained from a right lower extremity painless bulge, which began to be visibly noticeable by the patient 2 months prior to admission. There were no signs of allocated inflammation nor lower limb ischemia. Radiology revealed an irregular mass formation conformant with neoplasia. CLINICAL DISCUSSION: Surgical resection of the mass along with synthetic graft replacement of the concomitant vascular bundle. Histopathological analysis of the resected mass revealed a monophasic synovial spindle cell sarcoma. CONCLUSION: SS is a rare neoplasm poses a grave risk for patients due to its malignant pathophysiology and the wide margin of misdiagnoses. It is pivotal to set-up proper preoperative diagnostic guidelines for it and maintain high clinical suspicion so that we can bring down the high rates of the morbidity and mortality which ensue from this malignancy.
No takes yet. Share an insight, caveat, or question.
Hariri et al. (2022) conducted a case report in Synovial Spindle Cell Sarcoma (n=1). Surgical resection and synthetic graft replacement was evaluated on Histopathological diagnosis and clinical management. Surgical resection with synthetic graft replacement successfully managed a rare monophasic synovial spindle cell sarcoma in a 46-year-old male.
Synapse has enriched 10 related papers. Consider them for comparative context: